ARS Pharmaceuticals, Inc.

Q1 2025 13F Holders

Symbol
SPRY
CUSIP
82835W108
Type
Equity
Class
COM
Num filings
193
Total reported value, excl. options
$960 M
Manager Report Date Value ($000) Shares Option Type